Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 8 of 8

Publication Record

Connections

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Kennedy VE, Savani BN, Greer JP, Kassim AA, Engelhardt BG, Goodman SA, Sengsayadeth S, Chinratanalab W, Jagasia M
(2016) Biol Blood Marrow Transplant 22: 1801-1807
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Busulfan, Calcineurin Inhibitors, Cyclophosphamide, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, B-Cell, Methotrexate, Middle Aged, Prognosis, Retrospective Studies, Rituximab, Survival Analysis, Transplantation Conditioning, Transplantation, Homologous, Vidarabine
Added July 28, 2016
0 Communities
1 Members
0 Resources
19 MeSH Terms
Targeted Busulfan therapy with a steady-state concentration of 600-700‚ÄČng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant.
Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E
(2014) Bone Marrow Transplant 49: 366-9
MeSH Terms: Adolescent, Age Factors, Anemia, Sickle Cell, Antilymphocyte Serum, Bone Marrow Transplantation, Busulfan, Child, Child, Preschool, Cyclophosphamide, Disease-Free Survival, Female, Follow-Up Studies, HLA Antigens, Humans, Immunosuppressive Agents, Infant, Male, Neutrophils, Siblings, Treatment Outcome
Added March 10, 2014
1 Communities
2 Members
0 Resources
20 MeSH Terms
Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis.
Hussein AA, Hamadah T, Domm J, Al-Zaben A, Frangoul H
(2013) Pediatr Transplant 17: 815-9
MeSH Terms: Blood Platelets, Busulfan, Child, Preschool, Cohort Studies, Cyclophosphamide, Female, Follow-Up Studies, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Immunosuppressive Agents, Infant, Male, Neutrophils, Primary Myelofibrosis, Stem Cells, Transplantation Conditioning, Treatment Outcome
Added March 7, 2014
0 Communities
1 Members
0 Resources
18 MeSH Terms
Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.
Hussein AA, Al-Zaben A, Ghatasheh L, Natsheh A, Hammada T, Abdel-Rahman F, Abu-Jazar H, Sharma S, Najjar R, Frangoul H
(2013) Pediatr Blood Cancer 60: 1345-9
MeSH Terms: Adolescent, Adult, Antilymphocyte Serum, Busulfan, Child, Child, Preschool, Cyclophosphamide, Disease-Free Survival, Female, Follow-Up Studies, Graft Rejection, Graft Survival, Hematopoietic Stem Cell Transplantation, Humans, Immunologic Factors, Infant, Male, Myeloablative Agonists, Retrospective Studies, Risk Factors, Survival Rate, Tissue Donors, Transplantation Conditioning, Transplantation, Homologous, Vidarabine, beta-Thalassemia
Added March 7, 2014
0 Communities
1 Members
0 Resources
26 MeSH Terms
Impact of conditioning regimen in allogeneic hematopoetic stem cell transplantation for children with acute myelogenous leukemia beyond first complete remission: a pediatric blood and marrow transplant consortium (PBMTC) study.
Sisler IY, Koehler E, Koyama T, Domm JA, Ryan R, Levine JE, Pulsipher MA, Haut PR, Schultz KR, Taylor DS, Frangoul HA
(2009) Biol Blood Marrow Transplant 15: 1620-7
MeSH Terms: Adolescent, Adult, Antineoplastic Agents, Alkylating, Bone Marrow Transplantation, Busulfan, Child, Child, Preschool, Cohort Studies, Cord Blood Stem Cell Transplantation, Disease-Free Survival, Female, Hematopoietic Stem Cell Transplantation, Humans, Infant, Leukemia, Myeloid, Acute, Male, Multivariate Analysis, Remission Induction, Retrospective Studies, Survival Rate, Transplantation Conditioning, Treatment Outcome, Whole-Body Irradiation, Young Adult
Added March 20, 2014
0 Communities
2 Members
0 Resources
24 MeSH Terms
Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA, Carter SL, Kernan NA, Kapoor N, Kamani NR, Brochstein JA, Frangoul H, Goyal RK, Horan JT, Pietryga D, Wagner JE, Kurtzberg J, COBLT Steering Committee
(2005) Biol Blood Marrow Transplant 11: 637-46
MeSH Terms: Antilymphocyte Serum, Antineoplastic Agents, Alkylating, Antineoplastic Combined Chemotherapy Protocols, Busulfan, Child, Preschool, Cord Blood Stem Cell Transplantation, Disease-Free Survival, Female, Graft Survival, Graft vs Host Disease, Histocompatibility Testing, Humans, Immunosuppressive Agents, Infant, Infant, Newborn, Leukemia, Male, Melphalan, Retrospective Studies, Transplantation Conditioning, Whole-Body Irradiation
Added March 27, 2014
0 Communities
1 Members
0 Resources
21 MeSH Terms
Bone marrow transplantation in pediatric patients with therapy-related myelodysplasia and leukemia.
Leahey AM, Friedman DL, Bunin NJ
(1999) Bone Marrow Transplant 23: 21-5
MeSH Terms: Bone Marrow Transplantation, Busulfan, Child, Child, Preschool, Cyclophosphamide, Female, Graft Survival, Humans, Immunosuppressive Agents, Infant, Leukemia, Male, Myelodysplastic Syndromes, Transplantation, Homologous, Treatment Outcome
Added March 27, 2014
0 Communities
1 Members
0 Resources
15 MeSH Terms
Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia.
Pawlowska AB, Blazar BR, Angelucci E, Baronciani D, Shu XO, Bostrom B
(1997) Bone Marrow Transplant 20: 915-20
MeSH Terms: Administration, Oral, Adolescent, Adult, Analysis of Variance, Bone Marrow Transplantation, Busulfan, Child, Child, Preschool, Cyclophosphamide, Humans, Immunosuppressive Agents, Liver Function Tests, Survival Analysis, Transplantation Conditioning, Transplantation, Homologous, beta-Thalassemia
Added December 10, 2013
0 Communities
1 Members
0 Resources
16 MeSH Terms